FLT3 and acute myeloid leukemia: However, given the earlier promising clinical data specifically in pediatric AML, the combination of sorafenib and cytotoxic chemotherapy for children with FLT3-ITD AML is currently under prospective investigation in the COG Phase 3 trial AAML1031 (NCT01371981) (33).